Email Alert | RSS

Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (4): 646-652. doi: 10.19723/j.issn.1671-167X.2019.04.009

Previous Articles     Next Articles

Comparison of efficacy and safety between two different methods of nephroureterectomy in two centers

Jin-feng WU1,Rong-cheng LIN2,You-cheng LIN1,Wang-hai CAI1,Qing-guo ZHU1,Dong FANG2,Geng-yan XIONG2,Lei ZHANG2,Li-qun ZHOU2,Lie-fu YE1,△(),Xue-song LI2,△()   

  1. 1. Department of Urology, Provincial Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Provicial Jinshan Hospital,Fuzhou, 350001, China
    2. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
  • Received:2019-03-20 Online:2019-08-18 Published:2019-09-03
  • Contact: Lie-fu YE,Xue-song LI E-mail:yeliefu@126.com;pineneedle@sina.com
  • Supported by:
    Supported by the Youth Project of the Health Commission of Fujian Province(2012-2-3)

RICH HTML

 14   

PDF (PC)

282

Abstract:

Objective: To compare the efficacy and safety of complete transperitoneal laparoscopic nephroureterectomy (CTNU) and traditional retroperitoneoscopic nehroureterectomy (TRNU) for the management of upper urinary tract urothelial carcinoma(UTUC).Methods: We retrospectively collected the clinical data of UTUC patients who underwent CTNU or TRNU surgery from January 2011 to December 2018 in Peking University First Hospital and Fujian Provincial Hospital, and compared the clinical characteristics, perioperative parameters, and follow-up results between the CTNU and TRNU surgeries.Results: Finally, a total of 266 cases were included, with 94 cases in the CTNU group and 172 cases in the TRNU group. The proportion of left side lesions was bigger in TRNU group when compared with CTNU group (P<0.05). No significant differences were observed in clinical characteristics, such as age, gender, body mass index(BMI), American society of anesthesiologists score(ASA score) and tumor laterality. All surgery procedures were completed. The vascular resparing was performed by reason that left arteria renalis was injured accidently during surgical operation in one case of TRNU group. No serious complications were observed in both CTNU and TRNU groups. In CTNU group, operating time was (202.9±76.7) min, estimated blood loss was (68.4±73.3) mL, drainage duration was (3.9±1.5) d, drainage volume was (181.7±251.5) mL, and postoperative hospital stay was (7.8±4.1) d. In TRNU group, operating time was (203.5±68.7) min, estimated blood loss was (130.2±252.1) mL, drainage duration was (4.3±1.6) d, drainage volume was (179.1±167.5) mL, and postoperative hospital stay was (8.2±3.7) d. The estimated blood loss in CTNU group was significantly less than that in TRNU group (P =0.005).The median follow-up time was 39 months (range: 1-88 months). The 5-year overall survival rate (OS), cancer specific survival rate (CSS), intra-vesical recurrence free survival rate (IvRFS), disease free survival rate (DFS) of CTNU group was 75.6%, 86.9%, 73.8%, 57.5%, respectively. The OS, CSS, IvRFS and DFS of TRNU group was 66.3%, 83.5%, 75.9%, 58.6%, respectively.No significant differences were observed in the OS, CSS, IvRFS and DFS between the CTNU and TRNU groups.Conclusion: CTNU technique is a safe and effective surgical option, and further prospective randomized controlled trial is needed for further evaluation.

Key words: Upper urinary tract, Urothelial carcinoma, Nephroureterectomy

CLC Number: 

  • R737.11

Figure 1

Four-point diamond layout"

Figure 2

Four-point rhombus layout"

Table 1

Clinical and pathological characteristics of all patients"

Items TRNU group(n=172) CTNU group(n=94) P value
Age/years, x?±s 67.1±11.5 66.0±9.2 0.437
Gender, n(%) 0.650
Male 92 (53.5) 53 (56.4)
Female 80 (46.5) 41 (43.6)
BMI(256 patients available)/(kg/m2), x?±s 24.4±2.9 23.9±3.4 0.342
Side, n(%) 0.001
Left 107 (62.2) 39 (41.5)
Right 65 (37.8) 55 (58.5)
Ureteroscopy, n(%) 0.517
Yes 29 (16.9) 13 (13.8)
No 143 (83.1) 81 (86.2)
ASA score (225 patients available), n(%) 0.085
1 6 (4.1) 9 (11.4)
2 112 (76.7) 59 (74.7)
3 28 (19.2) 11 (13.9)
Concomitant bladder cancer (206 patients available), n(%) 0.987
Yes 16 (11.2) 7 (11.1)
No 127 (88.8) 56 (88.9)
T stage, n(%) 0.523
Ta 4 (2.3) 2 (2.1)
T1 67 (39.0) 30 (31.9)
T2 50 (29.1) 30 (31.9)
T3 44 (25.6) 31 (33.0)
T4 5 (2.9) 1 (1.1)
Grade, n(%) 0.103
G1 51 (29.7) 37 (39.4)
G2 83 (48.3) 45 (47.9)
G3 38 (22.1) 12 (12.8)
Lymph node invasion, n(%) 0.403
N+ 7 (4.1) 6 (6.4)
N0 or Nx 165 (95.9) 88 (93.6)

Table 2

Intraoperative and postoperative situations of all patients"

Items TRNU group (n=172) CTNU group (n=94) P value
Operating time/min,x?±s 203.5±68.7 202.9±76.7 0.865
Estimated blood loss/mL,x?±s 130.2±252.1 68.4±73.3 0.005
Drainage duration/d,x?±s 4.3±1.6 3.9±1.5 0.090
Drainage volume/mL,x?±s 179.1±167.5 181.7±251.5 0.150
Postoperative hospital stay/d,x?±s 8.2±3.7 7.8±4.1 0.075
Perioperative complications,n/Clavien-Dindo grading 0.972
Intra-vesical hemorrhage 2/Ⅱ 1/Ⅱ
Reanal fossa hemorrhage 1/Ⅱ
Lymphatic fluid leakage 1/Ⅰ 1/Ⅰ
Ileus 1/Ⅱ

Figure 3

Follow-up results for TRNU and CTNU groups CTNU,complete transperitoneal laparoscopic nephroureterectomy; TRNU,traditional retroperitoneoscopic nephroureterectomy."

[1] Siegel RL, Miller KD, Jemal A , et al. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016,66(1):7-30.
[2] Roupret M, Babjuk M, Comperat E , et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update[J]. Eur Urol, 2017,73(1):111-122.
[3] 刘荣耀, 赵鹏举, 李学松 , 等. 经腹腔完全腹腔镜肾输尿管全长切除术治疗上尿路尿路上皮癌[J]. 北京大学学报(医学版), 2011,43(4):531-534.
[4] 李学松, 洪鹏, 丁光璞 , 等. 经腹完全腹腔镜肾输尿管全长切除术的关键技术总结(附光盘)[J]. 现代泌尿外科杂志, 2018,23(10):728-731.
[5] Clayman RV, Kavoussi LR, Figenshau RS , et al. Laparoscopic nephroureterectomy: initial clinical case report[J]. J Laparoendosc Surg, 1991,1(6):343-349.
[6] Ni S, Tao W, Chen Q , et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies[J]. Eur Urol, 2012,61(6):1142-1153.
[7] Ghazi A, Shefler A, Gruell M , et al. A novel approach for a complete laparoscopic nephroureterectomy with bladder cuff excision[J]. J Endourol, 2010,24(3):415-419.
[8] Mcdonald DF . Intussusception ureterectomy: a method of removal of the ureteral stump at time of nephrectomy without an additional incision[J]. Surg Gynecol Obstet, 1953,97(5):565-568.
[9] Gill IS, Soble JJ, Miller SD , et al. A novel technique for management of the en bloc bladder cuff and distal ureter during laparoscopic nephroureterectomy[J]. J Urol, 1999,161(2):430-434.
[10] Gill IS, Sung GT, Hobart MG , et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the cleveland clinic experience[J]. J Urol, 2000,164(5):1513-1522.
[11] Tsivian A, Benjamin S, Sidi AA . A sealed laparoscopic nephroureterectomy: a new technique[J]. Eur Urol, 2007,52(4):1015-1019.
[12] Jarrett TW, Chan DY, Cadeddu JA , et al. Laparoscopic nephroureterectomy for the treatment of transitional cell carcinoma of the upper urinary tract[J]. Urology, 2001,57(3):448-453.
[13] Yoshino Y, Ono Y, Hattori R , et al. Traditional retroperitoneoscopic nephroureterectomy for transitional cell carcinoma of the renal pelvis and ureter: Nagoya experience[J]. Urology, 2003,61(3):533-538.
[14] Hsi RS, Saint-Elie DT, Zimmerman GJ , et al. Mechanisms of hemostatic failure during laparoscopicnephrectomy: review of Food and Drug Administration database[J]. Urology, 2007,70(5):888-892.
[15] Liu P, Fang D, Xiong G , et al. A novel and simple modification for management of distal ureter during laparoscopic nephroureterectomy without patient repositioning a bulldog clamp technique and description of modified port placement[J]. J Endourol, 2016,30(2):195-200.
[16] Abe T, Shinohara N, Harabayashi T , et al. The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study[J]. BJU Int, 2008,102(5):576-580.
[17] Kondo T, Tanabe K . Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract[J]. Int J Urol, 2012,19(8):710-721.
[1] Si-da CHENG,Xin-fei LI,Sheng-wei XIONG,Shu-bo FAN,Jie WANG,Wei-jie ZHU,Zi-ao LI,Guang-pu DING,Ting YU,Wan-qiang LI,Yong-ming SUN,Kun-lin YANG,Lei ZHANG,Han HAO,Xue-song LI,Li-qun ZHOU. Robot-assisted laparoscopic upper urinary tract reconstruction surgery: A review of 108 cases by a single surgeon [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 771-779.
[2] Jun-hui ZHANG,Yi-hang JIANG,Yu-guang JIANG,Ji-qing ZHANG,Ning KANG. Clinical outcomes of simultaneous bilateral endoscopic surgery for bilateral upper urinary tract calculi [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 672-677.
[3] Bing-wei HUANG,Jie WANG,Peng ZHANG,Zhe LI,Si-cheng BI,Qiang WANG,Cai-bo YUE,Kun-lin YANG,Xue-song LI,Li-qun ZHOU. Application of indocyanine green in complex upper urinary tract repair surgery [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 651-656.
[4] Bao GUAN,Mai WENG,Hang FAN,Ding PENG,Dong FANG,Geng-yan XIONG,Xue-song LI,Li-qun ZHOU. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy: A single-center retrospective study of 686 patients [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1056-1061.
[5] Run-zhuo MA,Hai-zhui XIA,Min LU,Zhi-ying ZHANG,Qi-ming ZHANG,Jian LU,Guo-liang WANG,Lu-lin MA. Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 665-672.
[6] Si-da CHENG,Wan-qiang LI,Li MU,Guang-pu DING,Bo ZHANG,Cheng SHEN,Ze-wei YING,Kun-lin YANG,Han HAO,Xue-song LI,Li-qun ZHOU. Application of totally extraperitoneal renal autotransplantation with Boari flap-pelvis anastomosis in upper urinary tract urothelial carcinomas treatment [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 758-763.
[7] Guang-pu DING,Si-da CHENG,Dong FANG,Kun-lin YANG,Xue-song LI,Hui-xia ZHOU,Qian ZHANG,Xiong-jun YE,Li-qun ZHOU. Review of upper urinary modified minimal invasive surgical technology [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 610-614.
[8] TANG Xing-guo, YAN Ye, QIU Min, LU Jian, LU Min, HOU Xiao-fei, HUANG Yi, MA Lu-lin. Retrospective study of young bladder urothelial carcinoma from a single center within 16 years [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 630-633.
[9] MA Run-zhuo, QIU Min, HE Wei, YANG Bin, XIA Hai-zhui, ZOU Da, LU Min, MA Lu-lin1, LU Jian. Ureteroscope can assist risk stratification in upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 632-637.
[10] GUAN Bao, CAO Zhen-peng, PENG Ding, LI Yi-fan, ZHAN Yong-hao, LIU Li-bo, HE Shi-ming, XIONG Geng-yan, LI Xue-song, ZHOU Li-qun. Prognostic factors of patients with T2N0M0 upper tract urothelial carcinoma: a single-center retrospective study of 235 patients [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 603-607.
[11] LIU Jia-yuan, PENG Xiang, NING Xiang-hui, LI Teng, PENG Shuang-he, WANG Jiang-yi, LIU Sheng-jie, DING Yi, CAI Lin, GONG Kan. Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 585-589.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 516 -520 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd